Delivery Order SPE2DP25D0002-SPE2DP25F7967

Award Date 6/9/25
Potential Completion Date 7/31/25
Potential Value $5.9M
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
This is a $6,406,400.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., a subsidiary of the specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a completion date of January 19, 2024. Valneva USA has held similar indefinite delivery/indefinite quantity contracts and blanket purchase agreements with the Defense Logistics Agency and other federal agencies...
This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc., doing business as Intercell USA Inc. The contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a potential value of $3,203,200.00 and a completion date of January 19, 2024. Valneva USA, a subsidiary of the specialty vaccine company Valneva SE, has received numerous prime federal contract awards, primarily from the Defense Logistics...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO, with a ceiling value of $5,883,494.40 and a completion date of May 27, 2025. This contract is not set aside for any specific business category. Valneva USA, Inc. holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop...
The Department of Veterans Affairs Veterans Health Administration awarded a delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of Valneva SE, for the provision of the Japanese Encephalitis Virus Vaccine (IXIARO). This $249,648.00 firm fixed price contract has a completion date of March 25, 2025 and was awarded on March 26, 2024. The contract is under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not have a set-aside...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $14,201,021.80 firm-fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Department of Defense's medical countermeasures program. This delivery order is part of two larger Indefinite Delivery Contracts (IDCs) awarded to Valneva...
This is a delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Valneva USA, Inc. - doing business as Intercell USA Inc. - to provide the IXIARO Japanese encephalitis virus vaccine. The $247,897.00 firm fixed price delivery order was placed against Valneva's GSA Schedule 61 contract for Pharmaceuticals and Drugs. The delivery order has a completion date of March 15, 2022 and was awarded on February 15, 2022. This order is part of Valneva's broader...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the Japanese Encephalitis Vaccine (IXIARO). The $237,264.00 contract, which has no set-aside designation, will be performed in Bethesda, Maryland and runs through April 19, 2024. Valneva USA, Inc. is a subsidiary of the specialty vaccine company Valneva SE, which develops and manufactures vaccines to address...
  • SPE2DP25D0002
    Indefinite Delivery Contract
  • SPE2DP25D0002-SPE2DP25F7967
    Delivery Order

This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE, by the Medical Supply Chain division of the U.S. Department of Defense. The $5,883,494.40 contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a period of performance ending on July 31, 2025. Valneva USA, Inc. serves as the prime contractor and is responsible for vaccine production and delivery, primarily from its Potomac, Maryland facility. The contract is not designated as a set-aside and is being issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). This award is part of the Department of Defense's medical countermeasures program, which aims to ensure the availability of critical vaccines for military personnel and federal employees.

Generated 9/9/25, 12:47 PM